Drug Interactions & Adverse Effects

Three sets of training slides covering what providers treating people with HIV should know about COVID-19. Overall learning objectives include identif...

Hepatitis C Online is a free educational website from the University of Washington National Hepatitis Training Center. This project is funded by the C...

Archived webinar.

Objectives:

• Chronic pain in patients taking medications for opioid use disorder (MOUD)
• Acute pain in patients taking MOUD
• Acute pain in...

Learning Objectives:

• Recall processes and data from long-acting antiretroviral clinical trials
• Discuss why patients may desire long-acting antiretrovira...

Objectives:

• Consider potential pros and cons of switching to intramuscular (IM), long-acting cabotegravir-rilpivirine (LA CAB-RPV) for an individual wi...

Training slides review potential ARV drug-drug interactions and identify resources for the evaluation of drug-drug interactions.

Comprehensive guidelines, including:

• Testing, Evaluation, and Monitoring
• Management of Treatment-Naive Patients
• Management of Treatment-Experienced Patie...

Each year HRSA's HIV/AIDS Bureau sponsors a conference for Ryan White Program clinicians to learn about advances in care and treatment. The AETC Natio...

A collection of clinical guides regarding drug interactions of hepatitis C virus (HCV) direct-acting antivirals (DAAs) with other common primary care...

This digital glossary of HIV-related terms includes both lay and scientific descriptions and illustrations. Materials are in the public domain and may...

Training slides learning objectives include:

• Identifying factors that affect medication adherence for people with HIV
• Recognizing the importance of a pa...

Training slides learning objections include:

• Understanding the mechanism of action for drug interactions with hepatitis C medications
• Recognizing which...

Weekly newsletter about NEAETC’s upcoming educational programming and resources...

Description:

This training slide presents updated data long acting injectable (LAI) cabotegravir/rilpivirine for treatment. Differentiate monitoring st...

Description:

This Training Presentation will compare and contrast factors that affect medication adherence and apply a patient centered approach to ant...

Description:

This Training Presentation lists strategies that reduce the risk of meningitis in people with HIV (PWH). Demonstrates how to recognize cli...

This resource provides information to providers on the increased risk of cardiovascular (CV) disease in people with HIV, as well as prevention and tre...

These training slides guide providers in decision making on managing antiretroviral therapy and switching treatments, as well as discussions on preven...

These training slides outline the following topics:

•Global perspective of the HIV-cardiovascular disease association

•Mechanisms of atherosclerotic ca...

These slides discuss relevant drug-drug interactions between common antidepressants and
antiretroviral drugs.

These slides review case studies and updates on effectiveness of pre-exposure prophylaxis (PrEP) among different populations and regions.

These slides provide an overview of unhealthy alcohol use, the HIV care continuum and comorbidities, screening and interventions for unhealthy alcohol...

These guideline slides compare and contrast various antiretroviral therapy (ART) options when initiating treatment for people with HIV, as well as ind...

These slides discuss the importance of shared decision making in sexual health counseling and interactions of antiretroviral therapies with contracept...

These slides provide basic information on Dolutegravir-Rilpivirine, an antiretroviral therapy (ART) treatment, including key drug interactions and stu...

These slides provide an overview on the relationship between HIV and opioids and CDC's current opioid painkiller prescribing guidelines to people with...

This presentation discusses relevant selection criteria when rapidly initiating anti-retroviral therapy (ART), appropriate ART regimen for patients in...

This presentation provides information on basics of antiretroviral therapy (ART) classes, mechanisms of actions, "hidden" interactions with HIV medica...

These slides provide information on causes of creatinine elevation in people with HIV (PWH), workup of creatinine elevation, as well as the effects of...

These slides provide various topics related to HIV, such as testing and linkage to care, options for post-exposure prophylaxis (PEP) treatment, curren...

These guideline slides provide information and recommendations on statin therapy as primary prevention for cardiovascular disease. Antiretroviral ther...

This presentation provides an overview on the 4Ms framework and how it contributes to creating an Age Friendly Health System (AFHS). The 4Ms framework...

This presentation reviews the epidemiology of hepatitis C Virus (HCV) in the U.S., discusses HCV screening, diagnosis, pre-treatment evaluation, treat...

This presentation provides information on the current evidence supporting the use of long acting injectable cabotegravir (CAB-LA) for HIV prevention,...

This presentation reviews the health disparities in HIV infection and treatment among transgender/gender diverse individuals.

This presentation provides an overview on the epidemiology of perinatal HIV in the US, pre-exposure prophylaxis (PrEP) in the perinatal period, as wel...

The syndemic of HIV and sextually transmitted infection (STI) are described in this presentation. Novel STI prevention strategies like doxyPEP are dis...

This recorded webinar, summarizes the pharmacologic action and effectiveness, as well as the appropriateness of HIV treatment with cabotegravir/rilpiv...

These slides provide an overview, background, prevention, clinical manifestations and diagnosis, treatment, and medication side effects on Mycobacteri...